Evidence map›Paper›PMID 32331412›Full record

ReviewInternational journal of molecular sciences2020

Endocrine Disrupting Chemicals and Type 1 Diabetes.

Barbara Predieri, Patrizia Bruzzi, Elena Bigi, Silvia Ciancia, Simona F Madeo, Laura Lucaccioni, Lorenzo Iughetti

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Endocrine disruptors, insulin resistance, and diabetes.Turkish journal of medical sciences · 2025
    Review
  15. Mechanisms underlying sex differences in autoimmunity.The Journal of clinical investigation · 2024
    Review
  16. Endocrine disrupting chemicals and obesity prevention: scoping review.Journal of health, population, and nutrition · 2024
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Barbara PredieriPediatric Unit, Department of Medical and Surgical Sciences of the Mother, Children and Adults-University of Modena and Reggio Emilia, Largo del Pozzo, 71-41124 Modena, Italy.ORCID 0000-0002-3302-6886
Patrizia BruzziPediatric Unit, Department of Pediatrics-AOU Policlinic of Modena, Largo del Pozzo, 71-41124 Modena, Italy.
Elena BigiPediatric Unit, Department of Medical and Surgical Sciences of the Mother, Children and Adults-University of Modena and Reggio Emilia, Largo del Pozzo, 71-41124 Modena, Italy.
Silvia CianciaPost Graduate School of Pediatrics, Department of Medical and Surgical Sciences of the Mothers, Children and Adults-University of Modena and Reggio Emilia, Largo del Pozzo, 71-41124 Modena, Italy.
Simona F MadeoPediatric Unit, Department of Pediatrics-AOU Policlinic of Modena, Largo del Pozzo, 71-41124 Modena, Italy.
Laura LucaccioniNeonatal Intensive Care Unit, Department of Medical and Surgical Sciences of the Mother, Children and Adults-University of Modena and Reggio Emilia, Largo del Pozzo, 71-41124 Modena, Italy.
Lorenzo IughettiPediatric Unit, Department of Medical and Surgical Sciences of the Mother, Children and Adults-University of Modena and Reggio Emilia, Largo del Pozzo, 71-41124 Modena, Italy.ORCID 0000-0003-0370-7872
University of Modena and Reggio Emilia · ITAzienda Ospedaliero-Universitaria di Modena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 1 diabetes (T1D) is the most common chronic metabolic disease in children and adolescents. The etiology of T1D is not fully understood but it seems multifactorial. The genetic background determines the predisposition to develop T1D, while the autoimmune process against β-cells seems to be also determined by environmental triggers, such as endocrine disrupting chemicals (EDCs). Environmental EDCs may act throughout different temporal windows as single chemical agent or as chemical mixtures. They could affect the development and the function of the immune system or of the β-cells function, promoting autoimmunity and increasing the susceptibility to autoimmune attack. Human studies evaluating the potential role of exposure to EDCs on the pathogenesis of T1D are few and demonstrated contradictory results. The aim of this narrative review is to summarize experimental and epidemiological studies on the potential role of exposure to EDCs in the development of T1D. We highlight what we know by animals about EDCs' effects on mechanisms leading to T1D development and progression. Studies evaluating the EDC levels in patients with T1D were also reported. Moreover, we discussed why further studies are needed and how they should be designed to better understand the causal mechanisms and the next prevention interventions.

Indexed as

Disease SusceptibilityAnimalsClinical Studies as TopicDiabetes Mellitus, Type 1Disease Models, AnimalEndocrine DisruptorsEnvironmental ExposureHumansEndocrine Disruptorsbisphenol Aendocrine disruptorsnon-obese diabetic (NOD) micepesticidesphthalatespolychlorinated biphenylspolyfluorinated substancestype 1 diabetes

Identifiers

PMID32331412
PMCPMC7215452
OpenAlexW3017427438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.